AGP Sues Correlogic; Claims Company Defaulted on Loan by Misrepresenting OvaCheck Test
November 19, 2010
AGP Sues Correlogic; Claims Company Defaulted on Loan by Misrepresenting OvaCheck Test
In its suit the company asserted that the alleged misrepresentations put Correlogic in default on a $750,000 loan from AGP, and that as a result Correlogic is required under the loan agreement to grant AGP an exclusive license for the use of its intellectual property in Asia.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Quest Seeks to Stop Sale of Correlogic's Assets, Claims Rights to OvaCheck IP
April 15, 2011 / ProteoMonitor - Court Grants Correlogic's Motion to Reject Licenses Claimed by AGP
January 21, 2011 / ProteoMonitor - Court Orders Correlogic to Share IP Info with AGP
December 3, 2010 / ProteoMonitor - Date, Minimum Bids Set for Sale of Correlogic's Assets
May 27, 2011 / ProteoMonitor - Correlogic Sells AGP Limited Rights to OvaCheck Patents in Asia as Part of Legal Settlement
February 25, 2011 / ProteoMonitor